Renalytix Ai Plc-adr logo

Renalytix Ai Plc-adr Share Price Today (NASDAQ: RNLX)

Renalytix Ai Plc-adr share price is $0 & ₹0.00 as on 3 Oct 2024 IST

-0.2

(-100%)

Live

Bell Icon

The stock has been delisted from the stock exchange on 4 Oct 2024

View live Renalytix Ai Plc-adr share price in Dollar and Rupees. Guide to invest in Renalytix Ai Plc-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Renalytix Ai Plc-adr, along with analyst recommendations, forecasts, and comprehensive financials.

Renalytix Ai Plc-adr (RNLX) Key Statistics

in dollars & INR

Previous Close
$0.196
Open
$0.2098
Market Capitalization
$18.2M
Today's Volume
$866.5K
Revenue TTM
$2.3M
EBITDA
$-28.6M
Earnings Per Share (EPS)
$-0.62
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1073.18%

How to invest in Renalytix Ai Plc-adr Stock (RNLX) from India?

It is very easy for Indian residents to invest directly in Renalytix Ai Plc-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Renalytix Ai Plc-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Renalytix Ai Plc-adr or RNLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Renalytix Ai Plc-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Renalytix Ai Plc-adr shares which would translate to null fractional shares of Renalytix Ai Plc-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Renalytix Ai Plc-adr, in just a few clicks!

Global Institutional Holdings in Renalytix Ai Plc-adr

  • Pinnacle Associates Inc

    0.98%

  • Stifel Financial Corp

    0.68%

  • Easterly Investment Partners.

    0.67%

  • Tejara Capital Ltd

    0.60%

  • CI Private Wealth LLC

    0.40%

  • Nantahala Capital Management, LLC

    0.28%

Analyst Recommendation on Renalytix Ai Plc-adr

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Renalytix Ai Plc-adr(by analysts ranked 0 to 5 stars)

About Renalytix Ai Plc-adr

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.
Organization
Renalytix Ai Plc-adr
Employees
0
CEO
Mr. James R. McCullough M.B.A.
Industry
Technology Services

Important FAQs about investing in RNLX Stock from India :

Can Indians buy Renalytix Ai Plc-adr shares?

Yes, Indians can invest in the Renalytix Ai Plc-adr (RNLX) from India.

With INDmoney, you can buy Renalytix Ai Plc-adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Renalytix Ai Plc-adr at zero transaction cost.

How can I buy Renalytix Ai Plc-adr shares from India?

It is very easy to buy Renalytix Ai Plc-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Renalytix Ai Plc-adr (RNLX) be purchased?

Yes, you can buy fractional shares of Renalytix Ai Plc-adr with INDmoney app.

What are the documents required to start investing in Renalytix Ai Plc-adr stocks?

To start investing in Renalytix Ai Plc-adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Renalytix Ai Plc-adr?

Today's market capitalisation of Renalytix Ai Plc-adr RNLX is 18.2M

Who is the Chief Executive Officer (CEO) of Renalytix Ai Plc-adr ?

Mr. James R. McCullough M.B.A. is the current Chief Executive Officer (CEO) of Renalytix Ai Plc-adr.